You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石藥集團(1093.HK)拉昇創8個月新高價 密集披露多款產品最新研發進展
格隆匯 05-14 11:52
格隆匯5月14日丨石藥集團(1093.HK)強勢拉昇,盤中一度漲7.4%報10.6港元,股價創去年9月以來新高,市值超1200億港元。公司的研發投入目前逐步進入收穫期。5月11日公司連發四則公吿,密集披露集團最新研發進展。除集團重點產品鹽酸多柔比星脂質體注射液國內首家通過一致性評價,還有磷酸西格列汀片(100mg)、甲苯磺酸索拉非尼片(0.2g)和苯甲酸阿格列汀片(25mg)三個新產品獲得國家藥品監督管理局頒發藥品註冊批件,並視同通過仿製藥質量和療效一致性評價。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account